Author:
Bruno Savino,Mangia Alessandra
Reference7 articles.
1. Sustained virologic response rates with telaprevir by response after 4weeks of lead-in therapy in patients with prior treatment failure;Foster;J Hepatol,2013
2. Realize trial final results: telaprevir-based regimen for genotype 1 hepatitis C virus infection in patients with prior null response, partial response or relapse to Peg interferon/ribavirin;Zeuzem;J Hepatol,2011
3. Efficacy and safety of telaprevir-based regimen in cirrhotic patients with HCV genotype 1 and prior Peg interferon/ribavirin treatment failure;Pol;Hepatology,2011
4. Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis;Bruno;J Hepatol,2013
5. Different likelihood of achieving SVR on a telaprevir containing regimen among null responders, partial responders and relapsers irrespective of simolar responses after a peginterferon/ribavirin 4-week lead-in phase realize study sub analysis;Zeuzem;Hepatology,2012
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献